
Sep 22, 2026
HeartBeam Granted New U.S. Patent Expanding Acoustic Sensing for its ECG Device
HeartBeam Inc. has secured a new U.S. patent that integrates acoustic sensing and thoracic impedance measurement into its existing ECG device platform. This advancement allows the device to function as a "digital stethoscope" for assessing heart valve function and fluid accumulation, crucial for earlier detection of structural heart issues and heart failure. The patent strengthens HeartBeam's intellectual property and strategy for a multi-modal ambulatory cardiac sensing platform.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish